Respiratory Syncytial Virus Vaccine Market Is Extrapolated To Reach A Value Of USD 2.2 Billion By 2032
As per the current market research conducted by the CMI Team, the global Respiratory Syncytial Virus Vaccine Market size is expected to record a CAGR of 4.6% from 2023 to 2032. In 2022, the market size is projected to reach a valuation of USD 1.2 billion. By 2032, the valuation is anticipated to reach USD 2.2 billion. Respiratory Syncytial Virus (RSV) Vaccine...
0 Comments 0 Shares 204 Views